DB17806ExperimentalProtein Based Therapies
Urtoxazumab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Orf protein
- Also known as
- humanized monoclonal antibody against Shiga-like toxin II · Immunoglobulin g1, anti-(escherichia coli shiga-like toxin ii b subunit) (human-mouse monoclonal huvtm1.1 .gamma.-chain), disulfide with human-mouse monoclonal huvtm1.1 .kappa.-chain, dimer
- Code names
- TMA-15
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Urtoxazumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account